Neurodevelopmental Outcomes in Children with Down Syndrome and Infantile Spasms

Abstract

Down syndrome (DS) is the most common genetic cause of intellectual disability in the United States. The prevalence of seizure in individuals with DS is 1 to 13%, and infantile spasm (IS) occurs in 6 to 32% of those with seizures. Since IS is relatively common in children with DS, it is important to understand the impact IS has on the neurodevelopmental outcomes to provide appropriate anticipatory guidance to help maximize the potential of these children. Our study is the first to compare the neurodevelopmental outcomes of children with DS and IS (DS + IS) to children with DS and no history of seizures (DS − IS). Using the Bayley scales of infant and Toddler development III, we assessed the neurodevelopment of 29 subjects (8 DS + IS and 21 DS − IS). Neurodevelopmental outcome was poor in the DS + IS cohort, but the delay in treatment does not appear to contribute to any differences in their developmental scores. However, when compared with children with DS − IS, the DS + IS cohort scored approximately 20 points less in all domains including cognitive, motor, and language (p < 0.05). Our results indicate that IS may impact the neurodevelopmental outcomes of children with DS + IS; thus, it is important to provide ongoing developmental and educational assessments and potentially additional therapies for children with DS + IS.

Keywords

Down syndrome - infantile spasms - neurodevelopmental outcomes

• References

• 1 Parker SE, Mai CT, Canfield MA , et al; National Birth Defects Prevention Network. Updated National Birth Prevalence estimates for selected birth defects in the United States, 2004-2006. Birth Defects Res A Clin Mol Teratol 2010; 88 (12) 1008-1016
• 2 Smigielska-Kuzia J, Sobaniec W, Kułak W, Boćkowski L. Clinical and EEG features of epilepsy in children and adolescents in Down syndrome. J Child Neurol 2009; 24 (4) 416-420
• 3 Goldberg-Stern H, Strawsburg RH, Patterson B , et al. Seizure frequency and characteristics in children with Down syndrome. Brain Dev 2001; 23 (6) 375-378
• 4 Romano C, Tiné A, Fazio G , et al. Seizures in patients with trisomy 21. Am J Med Genet Suppl 1990; 7: 298-300
• 5 Sanmaneechai O, Sogawa Y, Silver W, Ballaban-Gil K, Moshé SL, Shinnar S. Treatment outcomes of West syndrome in infants with Down syndrome. Pediatr Neurol 2013; 48 (1) 42-47
• 6 Eisermann MM, DeLaRaillère A, Dellatolas G , et al. Infantile spasms in Down syndrome—effects of delayed anticonvulsive treatment. Epilepsy Res 2003; 55 (1-2) 21-27
• 7 Sehgal R, Gulati S, Sapra S, Tripathi M, Kabra M, Pandey RM. Neurodevelopmental and epilepsy outcome in children aged one to five years with infantile spasms—a North Indian cohort. Epilepsy Res 2014; 108 (3) 526-534
• 8 Partikian A, Mitchell WG. Neurodevelopmental and epilepsy outcomes in a North American cohort of patients with infantile spasms. J Child Neurol 2010; 25 (4) 423-428
• 9 Riikonen R. Long-term otucome of West syndrome: a study of adults with a history of infantile spasms. Epilepsia 1996; 37 (4) 367-372
• 10 Riikonen R. Infantile spasms: therapy and outcome. J Child Neurol 2004; 19 (6) 401-404
• 11 Appleton RE. West syndrome: long-term prognosis and social aspects. Brain Dev 2001; 23 (7) 688-691
• 12 Bayley N. Bayley Scales of Infant and Toddler Development. San Antonio: Harcourt Assessment Inc.; 2006
• 13 Pellock JM, Hrachovy R, Shinnar S , et al. Infantile spasms: a U.S. consensus report. Epilepsia 2010; 51 (10) 2175-2189
• 14 Buterbaugh A, Visootsak J. Implications of delayed diagnosis of infantile spasm in a child with Down syndrome. J Pediatr Neurol 2014; 12 (2) 105-107